Results
1
Stocks which the market has priced substantially different to their cash flows, which could imply risk.
1 companies
Kamada
Market Cap: ₪1.3b
Manufactures and sells plasma-derived protein therapeutics.
KMDA
₪22.87
7D
6.7%
1Y
-7.4%